23andMe Clinicalhealth is a company within the Healthcare category. 23andMe Clinicalhealth is a specialized division or initiative within 23andMe Holding Co. that focuses on integrating personal genetic data into clinical care pathways. It aims to provide consumers and healthcare providers with actionable medical insights through clinical-grade genetic information and telehealth integration.
23andMe Clinicalhealth is part of 23andMe Holding Co..
23andMe Clinicalhealth is rated Low Visibility on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for 23andMe Clinicalhealth is Moderate. Significant factual deltas detected. Some AI models omit key brand facts.
AI models classify 23andMe Clinicalhealth as a Phantom. Invisible to AI.
23andMe Clinicalhealth appeared in 1 of 6 sampled buyer-intent queries (17%). The brand is highly likely to be buried under results for the main 23andMe consumer site and news regarding the parent company's data privacy issues or financial health.
AI characterizes this brand as an attempt to bridge consumer genetics with formal medical care. While it accurately links the brand to 23andMe's data assets, it often struggles to define the specific service boundaries between a wellness report and a clinical diagnostic. Key gap: The brand name '23andMe Clinicalhealth' specifically is often conflated with either the standard 'Health + Ancestry' product or the 'Lemonaid Health' acquisition.
Of 4 key facts verified about 23andMe Clinicalhealth, 2 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 1 are retrieval-dependent and may be inaccurate without live search.
The specific legal and functional distinction between '23andMe Clinicalhealth' and the parent company's standard genetic reports.
Buyers turn to 23andMe Clinicalhealth for medically supervised genetic risk assessment programs, Traditional Primary Care: Consulting with a primary care physician to review genetic risks without a structured digital health platform., Concierge Medicine Groups: Hiring boutique concierge medical firms that specialize in longevity and genomic medicine., among 3 documented problem areas.
Buyers evaluating 23andMe Clinicalhealth typically ask AI models about "23andMe clinical genetic services", "clinicalhealth genetic testing reviews", "genomic health membership for patients", and 2 similar queries.
23andMe Clinicalhealth's main competitors are Ambry Genetics, Color Healthnode. According to AI models, these are the brands most frequently named alongside 23andMe Clinicalhealth in buyer-intent queries.
23andMe Clinicalhealth's core products are Clinical-grade genetic screening, personalized health reports, telehealth medical consultations..
23andMe Clinicalhealth uses Subscription (Membership-based health services) or Custom/Per-test fee..
23andMe Clinicalhealth serves Health-conscious consumers, patients with genetic predispositions, healthcare providers..
23andMe Clinicalhealth Leveraging one of the world's largest consumer genetic datasets to inform physician-led clinical care pathways.
Brand Authority Index (BAI) tier: Low Visibility (exact score locked for unclaimed brands)
Archetype: Phantom
https://optimly.ai/brand/23andme-clinicalhealth
Last analyzed: April 10, 2026
Founded: 2023 (estimated as current division)
Headquarters: Sunnyvale, California, USA